Lucid Diagnostics Inc

NASDAQ:LUCD   3:59:50 PM EDT
2.24
+0.06 (+2.75%)
Earnings Announcements

PAVmed Provides Business Update And Preliminary Fourth Quarter And Full Year 2021 Financial Results

Published: 03/29/2022 20:20 GMT
Lucid Diagnostics Inc (LUCD) - Pavmed Provides Business Update and Preliminary Fourth Quarter and Full Year 2021 Financial Results.
Q4 Prelim GAAP Loss per Share $0.20.
Revenue is expected to be $0.71 Million
Adjusted EPS is expected to be -$0.28

Next Quarter Revenue Guidance is expected to be $1.43 Million
Next Quarter EPS Guidance is expected to be -$0.28

More details on our Analysts Page.